Pharmaceutical

Subscribe

Despite increasing budget pressures, countries around the world are making substantial investments in pro-innovation policies and programs to lure the biopharmaceutical research sector away from the U.S., finds a

WASHINGTON — Reuters reports, experimental drugs that show a big effect early in development for treating serious or life-threatening diseases would get a faster and cheaper path to U.S. approval,

TAMPA, Fla. — ISPE will host an in-depth two-day conference that will bring together top industry leaders and regulators to examine global supply network challenges and solutions. The event, “Designing,

JM Science’s Potentiometric Titrator (COM-1700) can run four titrations and stirrers that easily allow end user to do different types of titration including potentiometric, photometric, polarization, and conductometric titrations in

One month from trial date, Brigham Young University and Pfizer Inc. settled a lawsuit Tuesday for $450 million over whether the Utah school had been cheated out of billions of

Novartis International has agreed to buy Fougera Pharmaceuticals, a maker of generic skin care medicine, for $1.525 billion in cash, reported by The New York Times. Under the terms of

The Associated Press reports, Pfizer Inc. said Tuesday that its first-quarter profit fell 19 percent, mainly because new generic competition to its blockbuster cholesterol pill Lipitor cut U.S. sales by

Specialty pharmaceutical company Warner Chilcott Plc said it would explore strategic options, including preliminary talks with potential buyers, Reuters reports. The company said it hired Goldman Sachs as its financial

WILMINGTON, Del. — Bayer Pharma AG is suing generic drug maker Watson Pharmaceuticals Inc. for allegedly infringing two U.S. patents for the erectile dysfunction drug Staxyn, Bloomberg reported. Bayer

NEW YORK — Pfizer Inc. has decided to sell its infant nutrition business as soon as next week, The New York Times reported. According to the story, Nestle appears